Fundraising FoxJAZZ Venture Partners — 2019 Investments
3 investments dated 2019 · listed companies and verified rows first · show all
Digital therapeutics developer behind Stanza, an FDA-authorized smartphone behavioral therapy for fibromyalgia symptoms.
BiotechHealthtechSan Francisco, US
Michael Rosenbluth(Executive Officer, Director)
BoardCorey McCann(Director)
Board seatZack LynchAndrew FirlikZack Lynch· per SEC Form D
Co-investorsKicker VenturesAlumni VenturesAME Cloud VenturesAsahi Kasei Corporate VenturesGaingelsMana Ventures+1 more
__Twitter.png)
Arrive Health provides in-workflow software that gives clinical care teams real-time insurance, medication cost, and coverage data plus automation for prior authorization and patient outreach.
Digital HealthHealthtechSaaS
Co-investorsCU Healthcare Innovation FundFirst Trust Capital PartnersMemorialCare Innovation FundUpslope VenturesWormhole Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.